Misclassification of coffee consumption data and the development of a standardised coffee unit measure de réir Paul Roderick, Sean Ewings, Robin Poole, Julie Parkes, Jonathan A Fallowfield

Faigh an téacs iomlán

A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease de réir Maria Jimenez Ramos, Timothy J. Kendall, Ignat Drozdov, Jonathan A. Fallowfield

Faigh an téacs iomlán

Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records de réir Ignat Drozdov, Benjamin Szubert, Ian A. Rowe, Timothy J. Kendall, Jonathan A. Fallowfield

Faigh an téacs iomlán

All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study de réir Oliver J. Kennedy, Jonathan A. Fallowfield, Robin Poole, Peter C. Hayes, Julie Parkes, Paul J. Roderick

Faigh an téacs iomlán

Reliable computational quantification of liver fibrosis is compromised by inherent staining variation de réir Stuart Astbury, Jane I Grove, David A Dorward, Indra N Guha, Jonathan A Fallowfield, Timothy J Kendall

Faigh an téacs iomlán

A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP) de réir Fiona J. Gifford, Philip D. J. Dunne, Graeme Weir, Hamish Ireland, Catriona Graham, Sharon Tuck, Peter C. Hayes, Jonathan A. Fallowfield

Faigh an téacs iomlán

Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease de réir Rohit Sinha, Khalida A. Lockman, Natalie Z.M. Homer, Edward Bower, Paul Brinkman, Hugo H. Knobel, Jonathan A. Fallowfield, Alan J. Jaap, Peter C. Hayes, John N. Plevris

Faigh an téacs iomlán

Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis de réir Andrea Dennis, Matt D. Kelly, Carolina Fernandes, Sofia Mouchti, Jonathan A. Fallowfield, Gideon Hirschfield, Michael Pavlides, Michael Pavlides, Michael Pavlides, Stephen Harrison, Stephen Harrison, Manu V. Chakravarthy, Rajarshi Banerjee, Arun Sanyal

Faigh an téacs iomlán

Study protocol: HepaT1ca – an observational clinical cohort study to quantify liver health in surgical candidates for liver malignancies de réir Damian J. Mole, Jonathan A. Fallowfield, Timothy J. Kendall, Fenella Welsh, Scott I. Semple, Velicia Bachtiar, Matt Kelly, Stephen J. Wigmore, O. James Garden, Henry R. Wilman, Rajarshi Banerjee, Myrddin Rees, Michael Brady

Faigh an téacs iomlán

Non-invasive assessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study de réir Anna M. Hoy, Natasha McDonald, Ross J. Lennen, Matteo Milanesi, Amy H. Herlihy, Timothy J. Kendall, William Mungall, Michael Gyngell, Rajarshi Banerjee, Robert L. Janiczek, Philip S. Murphy, Maurits A. Jansen, Jonathan A. Fallowfield

Faigh an téacs iomlán

Addition of hyaluronic acid to the FIB‐4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabet... de réir Sheila M. Grecian, Stela McLachlan, Jonathan A. Fallowfield, Peter C. Hayes, Indra Neil Guha, Joanne R. Morling, Stephen Glancy, Rachel M. Williamson, Rebecca M. Reynolds, Brian M. Frier, Nicola N. Zammitt, Jackie F. Price, Mark W. J. Strachan

Faigh an téacs iomlán

Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer. de réir Damian J Mole, Jonathan A Fallowfield, Ahmed E Sherif, Timothy Kendall, Scott Semple, Matt Kelly, Gerard Ridgway, John J Connell, John McGonigle, Rajarshi Banerjee, J Michael Brady, Xiaozhong Zheng, Michael Hughes, Lucile Neyton, Joanne McClintock, Garry Tucker, Hilary Nailon, Dilip Patel, Anthony Wackett, Michelle Steven, Fenella Welsh, Myrddin Rees, HepaT1ca Study Group

Faigh an téacs iomlán

Genome‐Wide Association Study of NAFLD Using Electronic Health Records de réir Cameron J. Fairfield, Thomas M. Drake, Riinu Pius, Andrew D. Bretherick, Archie Campbell, David W. Clark, Jonathan A. Fallowfield, Caroline Hayward, Neil C. Henderson, Peter K. Joshi, Nicholas L. Mills, David J. Porteous, Prakash Ramachandran, Robert K. Semple, Catherine A. Shaw, Cathie L.M. Sudlow, Paul R.H.J. Timmers, James F. Wilson, Stephen J. Wigmore, Ewen M. Harrison, Athina Spiliopoulou

Faigh an téacs iomlán

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial. de réir Victoria K Snowdon, Neil J Lachlan, Anna M Hoy, Patrick W F Hadoke, Scott I Semple, Dilip Patel, Will Mungall, Timothy J Kendall, Adrian Thomson, Ross J Lennen, Maurits A Jansen, Carmel M Moran, Antonella Pellicoro, Prakash Ramachandran, Isaac Shaw, Rebecca L Aucott, Thomas Severin, Rajnish Saini, Judy Pak, Denise Yates, Neelesh Dongre, Jeremy S Duffield, David J Webb, John P Iredale, Peter C Hayes, Jonathan A Fallowfield

Faigh an téacs iomlán